How can digital tools bridge health care gaps in developing regions, enabling rapid scaling of early dementia screening, and ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...